An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study-Reference-Cited by-同舟云学术

An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study

Published:2017-08-09 Issue:10 Volume:102 Page:958-962
ISSN:0003-9888
Container-title:Archives of Disease in Childhood
language:en
Short-container-title:Arch Dis Child

Author:

Nainani Viveka^ORCID,Galal Ushma,Buttery Jim,Snape Matthew D

Publisher

BMJ

Subject

Pediatrics, Perinatology and Child Health

Reference11 articles.

1. McKee S . Real world data back efficacy of GSK’s Bexsero. 2016 http://www.pharmatimes.com/news/real_world_data_back_efficacy_of_gsks_bexsero_1122744

2. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial;Gossger;JAMA,2012

3. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. 2013 https://www.nice.org.uk/guidance/cg160/chapter/1-recommendations

4. Public Health England. Using Paracetamol to prevent and treat fever after MenB vaccination: national Health Service. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/483408/9413-paracetamol-menB-2page-A4-08-web.pdf

5. Public Health England. The UK immunisation schedule 2015. 2015 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/400554/2902222_Green_Book_Chapter_11_v2_4.pdf

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France;PharmacoEconomics - Open;2024-05-23

2. A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB);Expert Review of Vaccines;2023-06-14

3. Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison;BMJ Paediatrics Open;2022-10

4. Epidemiology, clinical presentations and outcome of patients presenting to the emergency department after a COVID ‐19 vaccination: An observational study;Emergency Medicine Australasia;2022-05-26

5. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease;Infectious Diseases and Therapy;2021-12-07